Marrone Bio Innovations (NASDAQ:MBII) and Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations and valuation.
Institutional and Insider Ownership
41.9% of Marrone Bio Innovations shares are held by institutional investors. 2.9% of Marrone Bio Innovations shares are held by insiders. Comparatively, 3.5% of Kiwa Bio-Tech Products Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Risk & Volatility
Marrone Bio Innovations has a beta of -0.21, indicating that its share price is 121% less volatile than the S&P 500. Comparatively, Kiwa Bio-Tech Products Group has a beta of 5.62, indicating that its share price is 462% more volatile than the S&P 500.
This table compares Marrone Bio Innovations and Kiwa Bio-Tech Products Group’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Marrone Bio Innovations||-105.87%||-2,570.84%||-41.81%|
|Kiwa Bio-Tech Products Group||7.33%||23.66%||10.83%|
Valuation & Earnings
This table compares Marrone Bio Innovations and Kiwa Bio-Tech Products Group’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Marrone Bio Innovations||$18.17 million||9.63||-$30.92 million||($1.07)||-1.48|
|Kiwa Bio-Tech Products Group||$17.27 million||1.37||$5.30 million||N/A||N/A|
Kiwa Bio-Tech Products Group has lower revenue, but higher earnings than Marrone Bio Innovations.
This is a summary of recent ratings and target prices for Marrone Bio Innovations and Kiwa Bio-Tech Products Group, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Marrone Bio Innovations||0||1||2||0||2.67|
|Kiwa Bio-Tech Products Group||0||0||0||0||N/A|
Marrone Bio Innovations currently has a consensus target price of $2.35, suggesting a potential upside of 48.73%. Given Marrone Bio Innovations’ higher possible upside, analysts clearly believe Marrone Bio Innovations is more favorable than Kiwa Bio-Tech Products Group.
Kiwa Bio-Tech Products Group beats Marrone Bio Innovations on 6 of the 11 factors compared between the two stocks.
Marrone Bio Innovations Company Profile
Marrone Bio Innovations, Inc. provides bio-based pest management and plant health products primarily for agricultural and water markets in the United States and internationally. It offers herbicides; fungicides; nematicides; insecticides; algaecides for algae control; molluscicides for mussel and snail control; plant growth and stress regulators; and water treatment products for various applications, such as hydroelectric and thermoelectric power generation, industrial applications, drinking water, aquaculture, irrigation, and recreation. The company’s products include Regalia, a plant extract-based fungicidal biopesticide for plant disease control and plant health; and Grandevo, a bioinsecticide for insect and mite control to the growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens, and ornamental plants. It also provides Zequanox, a biomolluscicide that controls invasive mussels, which cause infrastructure and ecological damage primarily to power and industrial companies; and Venerate, a bioinsecticide, which controls chewing and sucking insects and mites, as well as flies and plant parasitic nematodes. In addition, the company offers Haven, an sun protectant product that reduces plant stress and dehydration; and Majestene and Zelto, a bionematicide to control soil-dwelling nematodes by preventing and reducing root galls, as well as reducing adult reproduction and egg hatch. Further, it provides Stargus and Amplitude, a biofungicide for improving plant health. Marrone Bio Innovations, Inc. provides its products directly through sales force, as well as through distributors. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was founded in 2006 and is headquartered in Davis, California.
Kiwa Bio-Tech Products Group Company Profile
Kiwa Bio-Tech Products Group Corporation, through its subsidiaries, develops, manufactures, distributes, and markets bio-technological products for the agricultural market primarily in the People’s Republic of China. It offers bacillus species and/or photosynthetic bacteria based biological organic and compound microbial fertilizers. The company has a strategic relationship with ETS (Tianjin) Biological Science and Technology Development Co., Ltd. to produce bio-fertilizers in the People’s Republic of China and internationally; and strategic cooperation agreements with the Beijing Zhongpin Agricultural Science and Technology Development Center, as well as China Academy of Agricultural Science’s Institute of Agricultural Resources & Regional Planning, and Institute of Agricultural Economy & Development. Kiwa Bio-Tech Products Group Corporation was founded in 2002 and is headquartered in Yangling, China.
Receive News & Ratings for Marrone Bio Innovations Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Marrone Bio Innovations and related companies with MarketBeat.com’s FREE daily email newsletter.
- [LLODO] Michigan state Dem pepper-sprayed, charged with DUI, resisting arrest, weapons possession: report
- [LLODO] Head of NYC’s posh Dalton School leaving at the end of 2021
- [LLODO] Chilling video captures moment a love triangle erupts in murder, revenge in NYC
- [LLODO] NYPD officers hit with Molotov cocktail and liquid chemical in face, police say
- [LLODO] California group files federal civil rights complaint over San Diego school district’s ‘racist’ teachings
- [LLODO] Podcast helped in hunt for 1996 killer of California student
- [LLODO] National weather forecast: Parts of Northeast could see more than a foot of snow
- [LLODO] Cuomo boasts he ‘invented’ NYS-scented hand sanitizer, faces no questions over scandals
- [LLODO] Teacher who decried NYC school’s ‘indoctrination’ put on remote work: ‘Feels like punishment’